Stay updated on Nivolumab Combo in Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Smoldering Myeloma Clinical Trial page.

Latest updates to the Nivolumab Combo in Smoldering Myeloma Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 removed. This is a minor site update with no changes to trial details.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a Locations section with Massachusetts and updated page revision to v3.3.3. The old Massachusetts Locations label and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now displays revision v3.3.2, replacing the previous v3.3.1 revision.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.3.1 replaces v3.2.0 on the page; this appears to be an administrative update with no impact on study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedDeleted the government funding/operating status notice from the page, a general site-wide message not related to the trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check74 days agoChange DetectedNo significant additions or deletions were detected between the two screenshots; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab Combo in Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Smoldering Myeloma Clinical Trial page.